LIfT BioSciences announces data demonstrating potent killing

- IMAN demonstrated potent direct killing of a patient derived pancreatic ductal adenocarcinoma tumouroid model - IMAN is the world's first neutrophil-based cell therapy, generated

Related Keywords

London , City Of , United Kingdom , Namrata Taak , Gemzar Gemcitabine , Alex Blyth , Lindsey Neville , Consilium Strategic Communications Mary Jane Elliott , Immunomodulatory Alpha Neutrophil , Checkpoint Inhibitors , Chief Executive Officer , Tumour Micro Environment , Tumour Infiltrating Lymphocytes , Neutrophil Only Leukocyte Infusion Therapy , Immunomodulatory Alpha Neutrophils , Strategic Communications Mary Jane Elliott , Lift , Iosciences , Nnounces , Data , Emonstrating , Kpotent , Milling , Pancreatic , Dancer , Umouroids ,